TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction. Banner

Category: menopause

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →

Read more

TGA accepts Lawley product for evaluation in postmenopausal women with HSDD.

TGA accepts Lawley product for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals Pty Ltd today announced… Continue Reading →

Read more

Global Consensus Position Statement on the Use of Testosterone Therapy for Women

The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal… Continue Reading →

Read more

Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address

  In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof…. Continue Reading →

Read more
Menopause specialists warn against dangers of “bioidentical hormones” thumbnail
Categories: ,

Menopause specialists warn against dangers of “bioidentical hormones”

On Monday 15th July 2019 in a comprehensive interview on the Life Matters program (ABC Radio National) two of Australia’s premier menopause specialists, Dr Elizabeth Farrell and… Continue Reading →

Read more

BBC Menopause and testosterone replacement therapy

Over 900 specialist menopause physicians from around the world attended The European Menopause and Andropause Society conference held in Berlin on 15-17th May 2019. Numerous… Continue Reading →

Read more

Effects of testosterone therapy in women – new systematic review and meta-analysis

It has been over a decade since the last systematic review and meta-analysis on the effects of testosterone for women was conducted as an… Continue Reading →

Read more

Hypoactive Sexual Desire Disorder (HSDD) re-defined

In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created… Continue Reading →

Read more

EDUCATION: View presentations on testosterone management in men and women

EDUCATION View presentations on testosterone management in men and women In June 2017 the Lawley website added a ‘Health Professional Section’. This password protected learning area will… Continue Reading →

Read more

The World Menopause Congress 2014

The 14th World Menopause Congress was held in Cancun Mexico from May 1-4, 2014. There were numerous sessions covering female sexual health in the… Continue Reading →

Read more